Matthias Bodenstedt
Finanzdirektor/CFO bei MOONLAKE IMMUNOTHERAPEUTICS
Vermögen: 34 Mio $ am 30.04.2024
Profil
Matthias Bodenstedt is currently the Director and Chief Financial Officer at Moonlake Immunotherapeutics Ltd., Moonlake Immunotherapeutics AG, and MoonLake Immunotherapeutics.
Prior to this, he worked as a Partner at McKinsey & Co., Inc. from 2015 to 2021.
Bodenstedt received his undergraduate degree from the University of Hannover, his graduate degree from the University of Cambridge, and his MBA from Columbia Business School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
15.03.2024 | 520 903 ( 0,87% ) | 22 Mio $ | 30.04.2024 | |
15.03.2024 | 294 473 ( 3,29% ) | 12 Mio $ | 30.04.2024 |
Aktive Positionen von Matthias Bodenstedt
Unternehmen | Position | Beginn |
---|---|---|
MOONLAKE IMMUNOTHERAPEUTICS | Finanzdirektor/CFO | 05.04.2022 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Finanzdirektor/CFO | 01.07.2021 |
Moonlake Immunotherapeutics Ltd. | Direktor/Vorstandsmitglied | 01.09.2021 |
Ehemalige bekannte Positionen von Matthias Bodenstedt
Unternehmen | Position | Ende |
---|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.06.2021 |
Ausbildung von Matthias Bodenstedt
Columbia Business School | Masters Business Admin |
University of Cambridge | Graduate Degree |
University of Hannover | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
Private Unternehmen | 3 |
---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
Moonlake Immunotherapeutics Ltd. |